Return On Equity of Tvardi Therapeutics, Inc. from 31 Dec 2013 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Tvardi Therapeutics, Inc. quarterly and annual Return On Equity in % history and change rate from 31 Dec 2013 to 30 Sep 2025.
  • Tvardi Therapeutics, Inc. Return On Equity for the quarter ending 30 Sep 2025 was 199%, a 184% increase year-over-year.
  • Tvardi Therapeutics, Inc. annual Return On Equity for 2024 was 92%.
  • Tvardi Therapeutics, Inc. annual Return On Equity for 2023 was -176%, a 288% decline from 2022.
  • Tvardi Therapeutics, Inc. annual Return On Equity for 2022 was -45%, a 12% decline from 2021.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Change (%)
Return On Equity, Annual (%)
Return On Equity, YoY Annual Change (%)

Tvardi Therapeutics, Inc. Quarterly Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2025 199% +129% +184% 01 Jul 2025 30 Sep 2025
Q2 2025 110% -138% -56% 01 Apr 2025 30 Jun 2025
Q1 2025 89% +668% 01 Jan 2025 31 Mar 2025
Q4 2024 92% +268% 01 Oct 2024 31 Dec 2024
Q3 2024 70% +165% 01 Jul 2024 30 Sep 2024
Q2 2024 247% +323% 01 Apr 2024 30 Jun 2024
Q1 2024 -579% -530% -1075% 01 Jan 2024 31 Mar 2024
Q4 2023 -176% -131% -288% 01 Oct 2023 31 Dec 2023
Q3 2023 -95% -52% -121% 01 Jul 2023 30 Sep 2023
Q2 2023 -76% -44% -141% 01 Apr 2023 30 Jun 2023
Q1 2023 -49% -5.2% -12% 01 Jan 2023 31 Mar 2023
Q4 2022 -45% -4.7% -12% 01 Oct 2022 31 Dec 2022
Q3 2022 -43% -54% -502% 01 Jul 2022 30 Sep 2022
Q2 2022 -31% -36% -864% 01 Apr 2022 30 Jun 2022
Q1 2022 -44% -52% -688% 01 Jan 2022 31 Mar 2022
Q4 2021 -41% -46% -921% 01 Oct 2021 31 Dec 2021
Q3 2021 11% +75% 01 Jul 2021 30 Sep 2021
Q2 2021 4.1% +70% 01 Apr 2021 30 Jun 2021
Q1 2021 7.5% +76% 01 Jan 2021 31 Mar 2021
Q4 2020 5% +74% 01 Oct 2020 31 Dec 2020
Q3 2020 -64% +6% +8.5% 01 Jul 2020 30 Sep 2020
Q2 2020 -66% +2.4% +3.5% 01 Apr 2020 30 Jun 2020
Q1 2020 -69% -1.5% -2.3% 01 Jan 2020 31 Mar 2020
Q4 2019 -69% -0.33% -0.48% 01 Oct 2019 31 Dec 2019
Q3 2019 -70% +0.47% +0.66% 01 Jul 2019 30 Sep 2019
Q2 2019 -68% +4.8% +6.6% 01 Apr 2019 30 Jun 2019
Q1 2019 -67% -9.9% -17% 01 Jan 2019 31 Mar 2019
Q4 2018 -69% +2.6% +3.6% 01 Oct 2018 31 Dec 2018
Q3 2018 -71% +21% +23% 01 Jul 2018 30 Sep 2018
Q2 2018 -73% +26% +27% 01 Apr 2018 30 Jun 2018
Q1 2018 -57% +60% +51% 01 Jan 2018 31 Mar 2018
Q4 2017 -72% +4.7% +6.1% 01 Oct 2017 31 Dec 2017
Q3 2017 -91% -41% -81% 01 Jul 2017 30 Sep 2017
Q2 2017 -100% -61% -159% 01 Apr 2017 30 Jun 2017
Q1 2017 -117% -83% -241% 01 Jan 2017 31 Mar 2017
Q4 2016 -76% -44% -139% 01 Oct 2016 31 Dec 2016
Q3 2016 -51% -20% -67% 01 Jul 2016 30 Sep 2016
Q2 2016 -38% +4.4% +10% 01 Apr 2016 30 Jun 2016
Q1 2016 -34% +0.82% +2.3% 01 Jan 2016 31 Mar 2016
Q4 2015 -32% -1.6% -5.1% 01 Oct 2015 31 Dec 2015
Q3 2015 -30% +19% +38% 01 Jul 2015 30 Sep 2015
Q2 2015 -43% +228% +84% 01 Apr 2015 30 Jun 2015
Q1 2015 -35% -56% -268% 01 Jan 2015 31 Mar 2015
Q4 2014 -30% -38% -503% 01 Oct 2014 31 Dec 2014
Q3 2014 -49% 01 Jul 2014 30 Sep 2014
Q2 2014 -271% 01 Apr 2014 30 Jun 2014
Q1 2014 21% 01 Jan 2014 31 Mar 2014
Q4 2013 7.6% 01 Oct 2013 31 Dec 2013

Tvardi Therapeutics, Inc. Annual Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
2024 92% +268% 01 Jan 2024 31 Dec 2024
2023 -176% -131% -288% 01 Jan 2023 31 Dec 2023
2022 -45% -4.7% -12% 01 Jan 2022 31 Dec 2022
2021 -41% -46% -921% 01 Jan 2021 31 Dec 2021
2020 5% +74% 01 Jan 2020 31 Dec 2020
2019 -69% -0.33% -0.48% 01 Jan 2019 31 Dec 2019
2018 -69% +2.6% +3.6% 01 Jan 2018 31 Dec 2018
2017 -72% +4.7% +6.1% 01 Jan 2017 31 Dec 2017
2016 -76% -44% -139% 01 Jan 2016 31 Dec 2016
2015 -32% -1.6% -5.1% 01 Jan 2015 31 Dec 2015
2014 -30% -38% -503% 01 Jan 2014 31 Dec 2014
2013 7.6% 01 Jan 2013 31 Dec 2013
* An asterisk sign (*) next to the value indicates that the value is likely invalid.